Skip to content

A study on the correlation of drug metabolism and human body composition based on the bioequivalence trial of Progesterone Sustained-release vaginal gel

A study on the correlation of drug metabolism and human body composition based on the bioequivalence trial of Progesterone Sustained-release vaginal gel

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115150
Enrollment
Unknown
Registered
2025-12-23
Start date
2024-06-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)Participants who have been successfully enrolled in the bioequivalence trials of Progesterone Sustained-release vaginal gel; 2)Have signed the informed consent form, have a full understanding of the content, process, and risks of this study, and can communicate well with the researchers.

Exclusion criteria

Exclusion criteria: Participants who may not be able to complete the study for other reasons or are deemed by the investigator to be unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Body composition;Blood pharmacokinetic parameters (Tmax, T1/2, Cmax, AUC0-t, AUC0-8);Safety;Pharmacokinetic parameters (Tmax T1/2 AUC0-t);

Countries

China

Contacts

Public ContactLi Ting

The Second Affiliated Hospital of Wenzhou Medical University

Liting1021@aliyun.com+86 577 88002664

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026